Aspira Women's Health Inc. Sustainability Profile
Aspira Women's Health Inc., headquartered in the United States, is a pioneering company in the women's health sector, focusing on innovative solutions for ovarian cancer detection and management. Founded in 2009, Aspira has made significant strides in developing advanced diagnostic tools, including its proprietary tests that leverage biomarkers to enhance early detection of ovarian cancer, a critical area in women's health. With a strong presence across major operational regions in North America, Aspira is committed to improving patient outcomes through its unique offerings, such as the Ova1 and OvaWatch tests. These products stand out for their ability to provide healthcare professionals with vital information, enabling informed decision-making. Aspira Women's Health has established itself as a leader in the industry, recognised for its dedication to advancing women's health and its contributions to cancer diagnostics.
DitchCarbon Score
How does Aspira Women's Health Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aspira Women's Health Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aspira Women's Health Inc.'s reported carbon emissions
Aspira Women's Health Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Aspira may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate strategies and targets to align with broader environmental goals.
How Carbon Intensive is Aspira Women's Health Inc.'s Industry?
How Carbon Intensive is Aspira Women's Health Inc.'s Location?
Aspira Women's Health Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aspira Women's Health Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
